<DOC>
	<DOCNO>NCT01350908</DOCNO>
	<brief_summary>Circulating tumor DNA detection quantification patient ovarian cancer .</brief_summary>
	<brief_title>Study Circulating Tumoral DNA Ovarian Cancer</brief_title>
	<detailed_description>Technique development : In first step , different available technique evaluate specificity sensibility use serial dilution cell line without TP53 mutation . Validation : The tumor DNA detection rate estimate patient 's blood ovarian cancer . The investigator study 25 patient obtain least 15 patient bear TP53 mutation could characterize primitive tumor metastasis . With 15 patient , investigator determine sensitive technique best cost/efficiency ratio .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Age &gt; = 18 year . Patient invasive ovarian cancer stage II IV FIGO classification . Patient treat surgery . Patient tumor metastasis available TP53 status characterization Patient able stand blood collection . Signed write informed consent approve AFSSAPS CPP . Patient without social protection / insurance . Borderline ovarian tumor . Non carcinoma ovarian tumor Patient invasive ovarian cancer 5 year diagnosis Current pregnancy lactation . All social , medical , psychological , situation make study impossible . Person deprive liberty .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>